In late December, the American Medical Association released our COVID-19 Vaccine Messaging Guide to the Federation and other key stakeholders. We recently made a few updates and adjustments to this guide, including publishing this resource on our website and translating this information into Spanish, to make it more broadly available to those who may benefit from this compilation of messaging. In addition to providing information reflective of public health guidance and AMA policy, we believe the content of this guide will be helpful to inform future legislative testimony, equipping spokespeople at the state level, and providing Federation communicators with social media content. It includes guidance on successful messaging and words to avoid, sample social media posts, information on how to handle detractors online, and how physicians can protect their online reputation.
The American Venous Forum (AVF) has joined other organizations to support the AMA’s letter to congressional leadership advocating that Congress pass legislation to extend the current moratorium on the two percent Medicare payment sequester beyond the March 31 expiration date. Specifically, the letter strongly urges Congress to pass H.R. 315, the “Medicare Sequester COVID Moratorium Act”—bipartisan legislation that would continue the current Medicare sequester moratorium for the duration of the public health emergency. View the letter here.
The AVF will continue to advocate for its members and our patients with every opportunity.
If not a member, please join the AVF to help strengthen our voice and to achieve our mission and vision.
In September of 2019, the Society for Vascular Surgery charged the members of its Diversity, Equity and Inclusion (DEI) Taskforce with envisioning a more diverse and inclusive SVS and vascular surgery workforce.
In December of 2020, their report (first link below) as well as the SVS Executive Board’s response and action plan to implement change (second link below) were published in the Journal of Vascular Surgery.
We applaud their efforts and encourage you to read and reflect on these two articles.
Ensuring Equity, Diversity and Inclusion in the Society for Vascular Surgery A Report of the Society for Vascular Surgery Task Force on Equity, Diversity and Inclusion
The Society for Vascular Surgery Executive Board response to the Diversity, Equity and Inclusion Taskforce Report
Interim data from NHLBI examining 3 international trials suggesting decreased morbidity and mortality for COVID-19 patients with therapeutic anticoagulation for patients not in the ICU. Please share this important summary. IT CAN SAVE LIVES.
Dear AVF Members,
We are delighted to share with you updated LCDs for the Medicare Administrative Contractors (MACs) First Coast and Novitas. These LCDs which are scheduled to take effect on 12/27/20, are felt to be very reasonable and appropriate concerning the care of our patients with venous disease. Through the prolonged efforts of the AVF Health Policy Committee, in conjunction with the SVS and the AVLS Health Policy Committee, we have LCDs that finally are appropriate for patients, providers, and payers. In the future, hopefully these will either translate to a National Coverage Determination (NCD), or similar LCDs with the other MACs. Thanks to all the current and past members of the AVF HPC, and our friends at SVS and AVLS for this achievement.
Harold J. Welch, MD – President, AVF
Mark D. Iafrati, MD – Chair, AVF Health Policy Committee
The AVF Health Policy Committee, in collaboration with the SVS and AVLS have been busy advocating for our patients and our members. This week, we submitted comment letters to CMS (Centers for Medicare and Medicaid Services) to address several significant regulatory issues. The first addresses a long-standing non-coverage decision regarding catheter based mechanical embolectomy for Pulmonary Embolism. The second addresses a proposed severe further reduction in the reimbursement for radiofrequency ablations over the next two years, based on an erroneous assumption about the prices we pay for RFA catheters. By raising our collective voices on these important issues, we hope push our agenda of educating the regulators and ensuring access to these vital services for our Medicare and Medicaid patients. Please take a moment to review these letters and feel free to add your voice with direct communication to your legislators in support of these important issues.